Brazil Threatens to Import Indian Copy of Roche Anti-HIV Drug

Law360, New York (December 28, 2003, 12:00 AM EST) -- Brazil may import an Indian generic version of the Nelfinavir anti-HIV drug produced Switzerland’s Roche Holding AG, in what would be its first step toward breaking the patent on the Swiss company’s product, a top Brazilian health official told the Reuters news agency.

Brazil’s health ministry calculates it could save $5 million in 2004 if it takes the Indian company’s drug. Negotiations with Roche are continuing, and Brazil’s government has repeatedly threatened to break the company’s patents as a tactic in its efforts to get a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.